Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD Centro Vena Acute Central Line (7 French Dual Lumen)

K-Number: K200266 · 2020-04-07

ApplicantBard Access Systems, Inc. (Bard Has Joined Bd)
Decision Date2020-04-07
Product CodeFOZ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

BD Centro Vena Acute Central Line (7 French Dual Lumen) is a medical device manufactured by Bard Access Systems, Inc. (Bard Has Joined Bd). It received FDA 510(k) clearance on 2020-04-07 under approval number K200266. The device is classified under product code FOZ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD Centro Vena Acute Central Line (7 French Dual Lumen)?

BD Centro Vena Acute Central Line (7 French Dual Lumen) is a medical device that received FDA 510(k) clearance on 2020-04-07. It is manufactured by Bard Access Systems, Inc. (Bard Has Joined Bd). The 510(k) number is K200266.

When was BD Centro Vena Acute Central Line (7 French Dual Lumen) approved by the FDA?

BD Centro Vena Acute Central Line (7 French Dual Lumen) received FDA 510(k) clearance on 2020-04-07, under approval number K200266.

What company makes BD Centro Vena Acute Central Line (7 French Dual Lumen)?

BD Centro Vena Acute Central Line (7 French Dual Lumen) is manufactured by Bard Access Systems, Inc. (Bard Has Joined Bd).

What is the FDA product code for BD Centro Vena Acute Central Line (7 French Dual Lumen)?

The FDA product code for BD Centro Vena Acute Central Line (7 French Dual Lumen) is FOZ.

Related Clinical Trials

NCT07039942 French Prospective Multicentric Study in Real World RECRUITING NCT06472518 Pharmaco Mechanical Thrombolysis Associated With Anticoagulation Compared With Anticoagulation in the Acute Phase of Very Symptomatic Proximal Venous Thrombosis of the Lower Limbs. RECRUITING NCT07585188 Neonatal Catheter Lock for Infection Prevention NOT_YET_RECRUITING NCT07580651 Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring NOT_YET_RECRUITING NCT07317102 Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) RECRUITING NCT04047784 Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients ENROLLING_BY_INVITATION

Other Devices by Bard Access Systems, Inc. (Bard Has Joined Bd)

K190855BD Acute Central Line

Related Devices (Code: FOZ)

K162894AccuCath Intravascular CatheterC.R. Bard, Inc. K161779MedSource TrueSafe Safety IV Catheter, MedSource TrueSafe Comfort Safety IV CatheterMedsource International, LLC K162377PowerGlide Pro Midline CatheterC.R. Bard, Inc. K161866BioFlo Midline CatheterNavilyst Medical, Inc. K161777BD Nexiva and BD Nexiva Diffusics Closed IV Catheter SystemsBecton Dickinson Infusion Therapy Systems, Inc. K160592SUPERCATH 6Togo Medikit Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑